La Jolla Institute Board of Directors elects top business leader
LA JOLLA, CA—The La Jolla Institute for Immunology (LJI) is pleased to announce that visionary business leader Richard S. Bodman
LA JOLLA, CA—The La Jolla Institute for Immunology (LJI) is pleased to announce that visionary business leader Richard S. Bodman
LA JOLLA, CA—Pandurangan Vijayanand (Vijay), M.D., Ph.D., has been appointed to the position of associate professor in the Division of
LA JOLLA, CA— One goal of immunotherapy is to rally a patient’s often over‐burdened immune cells to effectively attack a
LA JOLLA, CA—Multiple sclerosis, a debilitating neurological disease, is triggered by self-reactive T cells that successfully infiltrate the brain and
LA JOLLA, CA— Dr. Mitchell Kronenberg, President and Chief Scientific of Officer of the La Jolla Institute for Immunology has